Colgate-Palmolive (NYSE: CL ) is expected to report Q3 earnings on Oct. 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Colgate-Palmolive's revenues will expand 0.2% and EPS will grow 6.1%.
The average estimate for revenue is $4.39 billion. On the bottom line, the average EPS estimate is $1.39.
Last quarter, Colgate-Palmolive reported revenue of $4.27 billion. GAAP reported sales were 2.0% higher than the prior-year quarter's $4.19 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.33. GAAP EPS of $1.30 for Q2 were 3.2% higher than the prior-year quarter's $1.26 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 57.7%, 30 basis points better than the prior-year quarter. Operating margin was 23.3%, about the same as the prior-year quarter. Net margin was 14.7%, 20 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $17.22 billion. The average EPS estimate is $5.36.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,298 members out of 1,349 rating the stock outperform, and 51 members rating it underperform. Among 461 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 447 give Colgate-Palmolive a green thumbs-up, and 14 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Colgate-Palmolive is hold, with an average price target of $102.08.
Can your retirement portfolio provide you with enough income to last? You'll need more than Colgate-Palmolive. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.
- Add Colgate-Palmolive to My Watchlist.